Cannasouth has built a vibrant business management and research team with members experienced in advanced cannabinoid, cultivation, extraction, fractionation, and purification.
Cannasouth’s board members and directors have a broad range of business experience covering multiple industry sectors.
Our operational team includes GMP production processes and endocannabinoid system experts, with our research team supported by experts in neuropathic pain and organic chemistry.
Tony Ho – Independent Non-Executive Chairman
Tony has a Bachelor of Commerce degree from The University of New South Wales, Sydney, is a Member of The Institute of Chartered Accountants in Australia and New Zealand, a Fellow of The Institute of Chartered Secretaries and Administrators, a Fellow of the Australian Institute of Company Directors, and a Fellow of the Governance Institute of Australia. Tony holds numerous non-executive directorships with a number of ASX and NZX listed companies. He was previously a director of Yates New Zealand Limited.
Conor English – Independent Non-Executive Director
Conor has a broad agriculture background. He is Chairman of Agribusiness New Zealand Limited and NZX listed QEX Logistics Limited. He is a Director of GMP Pharmaceuticals Group Ltd, Esports New Zealand, and Quotable Value. He recently completed a 3 year term as one of only two external independent advisors to the Reserve Bank of New Zealand on monetary policy. He has had a number of other roles including 6 years as CEO of Federated Farmers. Conor has extensive good governance and business experience, with strong global insights around New Zealand products and exports, combined with strong international networks and relationships.
Mark Lucas – Executive Director and Chief Executive Officer
Mark is an experienced business manager who designs and implements operational business systems throughout Cannasouth. With strong data system DNA, Mark is a skilled manager who brings a wealth of business knowledge and experience to this role.
Mark’s business background spans 25 years. He is an entrepreneur by nature with a passion for business and has been involved in a number of businesses from initial conception through to mature, well-established companies. Mark’s key strengths include management, human resources/staff, project management, contract negotiation, sales and marketing, financial control, and business strategy.
Nic Foreman – Executive Director and Chief Operating Officer
Nic facilitates the implementation of the company’s agricultural and technical capacities. He also identifies opportunities for clinical research partnerships that will provide a better understanding of the therapeutic benefits of precise cannabinoid isolates for specific diseases. Nic’s business background has been focused on developing successful businesses in a number of sectors. Nic’s skill sets encompass, team inception, finance, management, marketing, technical expertise, research & development, legislative relationships, regulatory compliance, strategy and vision.
Rob Braithwaite – Chief Financial Officer
Rob is a chartered accountant with over 35 years’ experience within business advisory, corporate tax, planning and finance activities. As an Ex KPMG partner, Rob has a broad range of experience within this field both locally and internationally; he brings a rigorous commercial approach to tax planning and compliance.
Brenda van Zyl – Corporate Strategy Manager
Brenda’s recent business experience encompassed spending seven years in the USA leading a biotechnology manufacturing company from start-up, to fast growth, and right through to acquisition. Brenda has a Bachelor of Science and a Post-Graduate Diploma in Business and Administration and is an associate member of the New Zealand Institute of Directors. Her strengths are in the areas of innovation, vision, commercial management, progressive high-performance leadership and organisational culture management.